New Jersey S 3334: Establishes pilot program to provide Medicaid coverage of remote maternal health services for eligible beneficiaries.
Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2024-06-03)
State: New Jersey · Session: 221 · Bill: S 3334
Subjects: MEDICAID, WOMEN
Sponsors: Steinhardt, Douglas J., Testa, Michael L., McKnight, Angela V.
Bill Text
(Sponsorship Updated As Of: 5/12/2025)
SENATE, No. 3334
STATE OF NEW JERSEY
221st LEGISLATURE
INTRODUCED JUNE 3, 2024
Sponsored by:
Senator MICHAEL L. TESTA, JR.
District 1 (Atlantic, Cape May and Cumberland)
Senator DOUGLAS J. STEINHARDT
District 23 (Hunterdon, Somerset and Warren)
Co-Sponsored by:
Senator McKnight
SYNOPSIS
Establishes pilot program to provide Medicaid coverage of remote maternal
health services for eligible beneficiaries.
CURRENT VERSION OF TEXT
As introduced.
S3334 TESTA, STEINHARDT
2
AN ACT concerning Medicaid coverage of maternal health services 1
and supplementing Title 30 of the Revised Statutes. 2
3
BE IT ENACTED by the Senate and General Assembly of the State 4
of New Jersey: 5
6
1. As used in this act: 7
“Department” means the Department of Human Services. 8
“Health care provider” means a physician, a certified nurse 9
midwife, a professional midwife, or a midwife who is licensed 10
pursuant to Title 45 of the Revised Statutes. 11
“Medicaid” means the New Jersey Medical Assistance and 12
Health Services Program established pursuant to P.L.1968, c.413 13
(C.30:4D-1 et seq.) 14
“Remote maternal health services” means the use of digital 15
technology to collect medical and other forms of health data from a 16
pregnant Medicaid beneficiary and electronically transmit this 17
information, in a secure manner, to a health care provider at a 18
distant site for interpretation and use as part of a diagnosis or a 19
treatment plan. 20
“Remote non-stress test” means the use of a fetal monitoring 21
device, which is FDA cleared for at-home use to transmit fetal heart 22
rate, maternal heart rate, and uterine activity to a remote health care 23
provider. 24
“Remote patient monitoring” means the use of digital 25
technologies to collect medical and other forms of health data from 26
patients in one location and electronically transmit that information 27
securely to health care providers at a different location for analysis, 28
interpretation, and to make recommendations to, and manage the 29
treatment of, such patients. “Remote patient monitoring” shall 30
include the monitoring of clinical patient data such as weight, blood 31
pressure, pulse oximetry, respiratory flow rate, musculoskeletal 32
system status, blood glucose levels, and other patient-generated 33
physiological data. 34
“Tele-ultrasound” means the use of an ultrasound device that is 35
capable of sharing live streaming of ultrasound images that are 36
interpreted in real time by a health care provider that is in a 37
different location than the patient. Two-way audiovisual 38
communication with the remote healthcare provider may happen 39
through the ultrasound system or another device that is compliant 40
with the provisions of the federal “Health Insurance Portability and 41
Accountability Act of 1996.” 42
43
2. a. Contingent upon the receipt of federal reimbursement for 44
eligible State Medicaid expenditures, the Commissioner of Human 45
Services shall establish a voluntary, three-year pilot program to 46
provide remote maternal health services to pregnant Medicaid 47
S3334 TESTA, STEINHARDT
3
beneficiaries who are referred to the program by the beneficiary’s 1
health care provider. 2
b. The Commissioner of Human Services shall, based upon 3
clinical evidence and the recommendations of experts in the 4
practice of obstetrics and maternal-fetal medicine, determine the 5
menu of remote maternal health services that will be available 6
through the pilot program, which services shall, at a minimum, 7
include: 8
(1) remote patient monitoring; 9
(2) remote non-stress tests; and 10
(3) tele-ultrasound. 11
c. Any patient health data collected and transmitted, pursuant 12
to the remote maternal health services pilot program, shall be 13
collected and transmitted by a device that is compliant with the 14
requirements of the federal “Health Insurance Portability and 15
Accountability Act of 1996” (42 U.S.C. s.1320d et seq.) and that 16
has received approval for use in this capacity by the United States 17
Food and Drug Administration. 18
19
3. a. A pregnant individual who is enrolled in the Medicaid 20
program is eligible to participate, on a voluntary basis, in the 21
remote maternal health services pilot program, established pursuant 22
to section 2 of this act, provided the Medicaid beneficiary’s health 23
care provider determines that: 24
(1) remote maternal health services meet the standard of care; or 25
(2) the beneficiary has an increased liView New Jersey S 3334 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.